In AD and aging models, quercetin has been shown to restore cognitive function, inhibit tau phosphorylation, and reduce amyloid burden, indicating its potential as a multitarget compound for the prevention and treatment of AD [11,12]. This evidence concerns the gene MAPT and Alzheimer disease.